Nicholas Clarkson

Nicholas Clarkson

Company: Oxford Biomedica

Job title: Vice President and Head of Platform Research


Advances in Lentiviral Technology and Manufacturing Processes 12:15 pm

Novel lentiviral genomes and associated technology to improve productivity, quality, and enhanced safety Generation of stable, inducible, lentiviral vector producer cell lines (PCL’s) for CAR therapy Development of an improved production process to increase yield, reduce residual contaminants and improve qualityRead more

day: Day 2 - Track C - Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.